Wnt5a participates in hepatic stellate cell activation observed by gene expression profile and functional assays

Table 3 Signaling pathway related to activation of hepatic stellate cells

Terms	Count	Percent	P value	Fold enrichment	Benjamini
rno04510: Focal adhesion	51	4.73	6.34E-19	4.16	9.90E-17
rno04512: Extracellular matrix-receptor interaction	27	2.50	9.93E-13	5.30	7.75E-11
rno04810: Regulation of actin cytoskeleton	36	3.34	5.18E-08	2.74	2.69E-06
rno05200: Pathways in cancer	40	3.71	2.74E-05	2.00	0.001066
rno05414: Dilated cardiomyopathy	18	1.67	3.27E-05	3.18	0.00102
rno05410: Hypertrophic cardiomyopathy	17	1.57	5.01E-05	3.22	0.001302
rno04350: Transforming growth factor-beta signaling pathway	17	1.57	6.76E-05	3.148	0.001505
rno04540: Gap junction	15	1.39	4.27E-04	2.94	0.008302
rno04110: Cell cycle	19	1.76	7.69E-04	2.40	0.013254
rno04666: Fc gamma R-mediated phagocytosis	15	1.39	0.001011	2.71	0.015653
rno05222: Small cell lung cancer	14	1.29	0.001758	2.68	0.024645
rno04062: Chemokine signaling pathway	22	2.04	0.002121	2.04	0.027229
rno04115: p53 signaling pathway	12	1.11	0.002359	2.89	0.027945
rno05211: Renal cell carcinoma	12	1.11	0.003385	2.76	0.03708
rno04310: Wnt signaling pathway	19	1.76	0.003846	2.08	0.039281
rno04670: Leukocyte transendothelial migration	16	1.48	0.005063	2.21	0.048281
rno04010: MAPK signaling pathway	28	2.59	0.008006	1.67	0.071107
rno05219: Bladder cancer	7	0.64	0.022754	3.09	0.172201
rno04270: Vascular smooth muscle contraction	14	1.29	0.0235	1.97	0.169299
rno05212: Pancreatic cancer	10	0.92	0.027028	2.30	0.184168